Health
Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants – News-Medical.Net
A new study describes the use of DARPin (designed ankyrin repeat proteins) therapeutic agents, each of which contains three different DARPin domains within the…
The ongoing coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resisted successful containment by most non-pharmaceutical measures. Vaccination and natural immunity appear to be the only definitive methods to attain population immunity, and thus lead to a return to global normalcy. However, effective therapies continue to be sought after to reduce the high mortality rate from severe COVID-19 disease.
A new preprint on the bioRxiv*…
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General19 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers